Myda Advisors LLC Eli Lilly & CO Transaction History

Myda Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $4.91 Million - $6.57 Million	14,000 New	14,000 $6.57 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $1.34 Million - $1.57 Million	-12,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $1.27 Million - $1.42 Million	12,000 New	12,000 $1.39 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.